U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07222930) titled 'Learning Amyloid and Tau Results' on Oct. 29.
Brief Summary: This is a prospective, single-cohort, single-center, observational study to assess if learning one's Alzheimer's disease biomarker test result impacts longitudinal psychosocial, behavioral, and neuropsychological outcomes, and to identify factors that moderate and mediate these outcomes. Participants enrolled in this study are requested to complete surveys at four timepoints after learning their Alzheimer's biomarker test results.
Study Start Date: Oct., 2025
Study Type: OBSERVATIONAL
Condition:
Alzheimer Disease
Intervention:
OTHER: Disclose amyloid, tau results
Re...